The ASIST study will assess the safety and efficacy of BXQ-350 plus SOC, modified FOLFOX7 (mFOLFOX7) and bevacizumab, in patients with newly diagnosed mCRC. The study is also evaluating whether the ...

JonesTrading analyst Debanjana Chatterjee has reiterated their bullish stance on NTLA stock, giving a Buy rating on November 13. Debanjana ...

An expert has flagged the common signs of diabetes, including a common nighttime habit. As World Diabetes Day was marked on ...

And these data are really quite interesting and impressive that if you don't progress and that your time on [enfortumab ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

University of Sheffield spinout company, Rinri Therapeutics, a company focused on developing new treatments for hearing loss ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis.

Dr Menon believes that lifestyle modifications are “essential in managing diabetes and preventing complications.” His ...

A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...

Symptom screening improved symptom scores among children with cancer compared with usual care, two randomized trials showed.

The study was conducted at the Federal University of São Paulo and involved 144 diabetic patients, who were treated with ...